Avai Bio (AVAI) Total Liabilities (2018 - 2026)

Avai Bio (AVAI) has 9 years of Total Liabilities data on file, last reported at $3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 89.41% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (up 89.41% YoY), and the FY2026 full-year result was $3.4 million, up 89.41% from the prior year.
• Total Liabilities grew to $3.4 million in Q1 2026, from $3.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $3.4 million in Q1 2026 to a low of $758471.0 in Q3 2022.
• A 5-year average of $1.7 million and a median of $1.8 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities declined 24.78% in 2022 and jumped 105.26% in 2023, its largest moves.
• Tracing AVAI's Total Liabilities over 5 years: stood at $824372.0 in 2022, then soared by 105.26% to $1.7 million in 2023, then surged by 36.54% to $2.3 million in 2024, then advanced by 28.43% to $3.0 million in 2025, then grew by 14.17% to $3.4 million in 2026.
• Business Quant data shows AVAI's Total Liabilities at $3.4 million in Q1 2026, $3.0 million in Q4 2025, and $2.5 million in Q3 2025.